Ocular inflammation and infection represent a high-volume Ophthalmic Drugs Market Segment that is currently undergoing a shift toward more targeted, steroid-sparing agents. Chronic conditions like uveitis and allergic conjunctivitis can lead to permanent damage if not managed correctly, but long-term use of traditional corticosteroids carries risks like cataracts and increased eye pressure....